PULSATILLA VULGARIS

N/A

86 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PULSATILLA VULGARIS

PULSATILLA VULGARIS is a medication tracked in the FDA Adverse Event Reporting System (FAERS). The most commonly reported adverse reactions for PULSATILLA VULGARIS include HYPOTHERMIA, ABORTION INDUCED, AMNIOTIC CAVITY DISORDER, AMNIOTIC FLUID VOLUME DECREASED, ANXIETY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PULSATILLA VULGARIS.

Top Adverse Reactions

HYPOTHERMIA5 reports
ABORTION INDUCED2 reports
AMNIOTIC CAVITY DISORDER2 reports
AMNIOTIC FLUID VOLUME DECREASED2 reports
ANXIETY2 reports
ARTHRALGIA2 reports
DIZZINESS2 reports
DRUG INEFFECTIVE2 reports
FATIGUE2 reports
HAEMATOMA2 reports
MYALGIA2 reports
ABORTION SPONTANEOUS1 reports
ALLERGY TO CHEMICALS1 reports
ALOPECIA1 reports
ANAEMIA1 reports
ARRHYTHMIA1 reports
ASTHENIA1 reports
AUTOIMMUNE DISORDER1 reports
BONE DEFORMITY1 reports
BURNING SENSATION1 reports
CONJUNCTIVITIS1 reports
DEPRESSED MOOD1 reports
DRUG EXPOSURE DURING PREGNANCY1 reports
DRUG HYPERSENSITIVITY1 reports
DRUG LEVEL BELOW THERAPEUTIC1 reports
DRY EYE1 reports
DRY MOUTH1 reports
DRY SKIN1 reports
EYE BURNS1 reports
FEBRILE CONVULSION1 reports
GASTROINTESTINAL DISORDER1 reports
GENERALISED ERYTHEMA1 reports
GINGIVAL SWELLING1 reports
GLOSSODYNIA1 reports
HEAD DISCOMFORT1 reports
HEADACHE1 reports
HELICOBACTER GASTRITIS1 reports
HOT FLUSH1 reports
HYPERGAMMAGLOBULINAEMIA1 reports
HYPOGAMMAGLOBULINAEMIA1 reports
HYPOVITAMINOSIS1 reports
INTRACRANIAL PRESSURE INCREASED1 reports
IRON DEFICIENCY1 reports
JOINT LOCK1 reports
LIP EROSION1 reports
MATERNAL EXPOSURE DURING PREGNANCY1 reports
METRORRHAGIA1 reports
MUSCULOSKELETAL DISCOMFORT1 reports
MUSCULOSKELETAL PAIN1 reports
MYOSITIS1 reports
OCULAR DISCOMFORT1 reports
OFF LABEL USE1 reports
PAIN1 reports
PAIN IN EXTREMITY1 reports
PALPITATIONS1 reports
PAPILLOEDEMA1 reports
PERIPHERAL SWELLING1 reports
PERIPHERAL VASCULAR DISORDER1 reports
PHOTOSENSITIVITY REACTION1 reports
PRODUCT SUBSTITUTION ISSUE1 reports
PRODUCT USE ISSUE1 reports
PRURITUS1 reports
PULMONARY EOSINOPHILIA1 reports
RASH1 reports
SKIN DISORDER1 reports
SLUGGISHNESS1 reports
STRESS1 reports
THROAT IRRITATION1 reports
VISUAL ACUITY REDUCED1 reports
VISUAL IMPAIRMENT1 reports
WEIGHT DECREASED1 reports
WEIGHT INCREASED1 reports

Demographics Breakdown

Reports by Age

Age 43 reports
Age 61 reports
Age 81 reports
Age 291 reports
Age 421 reports
Age 661 reports
Age 671 reports
Age 701 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PULSATILLA VULGARIS?

This profile reflects 86 FDA FAERS reports that mention PULSATILLA VULGARIS. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PULSATILLA VULGARIS?

Frequently reported terms in FAERS include HYPOTHERMIA, ABORTION INDUCED, AMNIOTIC CAVITY DISORDER, AMNIOTIC FLUID VOLUME DECREASED, ANXIETY, ARTHRALGIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.